Romidepsin Patent Expiration

Romidepsin was first introduced by Bristol-Myers Squibb Co in its drug Istodax on Nov 5, 2009. Another drug containing Romidepsin is Romidepsin. 3 different companies have introduced drugs containing Romidepsin.


Romidepsin Patents

Given below is the list of patents protecting Romidepsin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Istodax US7608280 Method of producing FR901228 Aug 22, 2021

(Expired)

Bristol-myers
Istodax US7611724 Method of producing FR901228 Aug 22, 2021

(Expired)

Bristol-myers
Istodax US4977138 FR901228 substance and preparation thereof Aug 22, 2013

(Expired)

Bristol-myers



Romidepsin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Romidepsin Generic API Manufacturers

Only one generic application has been filed for Romidepsin.

Given below is the list of companies who have filed for Romidepsin generic, along with the locations of their manufacturing plants worldwide.